![Jens-Peter Volkmer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Actieve functies van Jens-Peter Volkmer
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
FORTY SEVEN, INC. | Oprichter | 01-01-2014 | - |
Corporate Officer/Principal | 01-01-2014 | - | |
48 Bio, Inc.
![]() 48 Bio, Inc. Pharmaceuticals: MajorHealth Technology 48 Bio, Inc. manufactures pharmaceutical and medicine. The CEO of the American company is Jens-Peter Volkmer. | Algemeen Directeur | - | - |
Financieel Directeur/CFO | - | - |
Loopbaan van Jens-Peter Volkmer
Statistieken
Internationaal
Verenigde Staten | 3 |
Operationeel
Founder | 1 |
Corporate Officer/Principal | 1 |
Chief Executive Officer | 1 |
Sectoraal
Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Forty Seven, Inc.
![]() Forty Seven, Inc. Pharmaceuticals: MajorHealth Technology Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities. The company was founded by Irving L. Weissman, Ravi Majeti, Mark Chao and Jens-Peter Volkmer in 2014 and is headquartered in Menlo Park, CA. | Health Technology |
48 Bio, Inc.
![]() 48 Bio, Inc. Pharmaceuticals: MajorHealth Technology 48 Bio, Inc. manufactures pharmaceutical and medicine. The CEO of the American company is Jens-Peter Volkmer. | Health Technology |
- Beurs
- Insiders
- Jens-Peter Volkmer
- Ervaring